Find Articles in:
All
Business
Reference
Technology
News
Lifestyle

Manufacturing Industry

LILLY (ELI) & COMPANY - Lilly Submits New Drug Application for EVISTA.

PR Newswire UK Disclose, December, 2006

 
For Release: December 7, 2006 
 
Refer to: Sharon Corbitt 
 
Office: (317) 277-1574 
 
Mobile: (317) 997-1206 
 
E-mail: corbittsd@lilly.com 
 
Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of 
              Invasive Breast Cancer Risk in Postmenopausal Women 
 
   Submission Is Largest In Lilly History, Including Data From Approximately 
                                 37,000 Women 
 
INDIANAPOLIS, IN - Eli Lilly and Company (NYSE: LLY) announced today that it 
submitted a New Drug Application (NDA) to the U.S. Food and Drug 
Administration's Division of Drug ...
 

BNET TalkbackShare your ideas and expertise on this topic

The following tags are supported in BNET comments:
<b></b> <i></i> <u></u> <pre></pre>

Leave a Reply

  1. You are currently a guest | Login?
advertisement
Go
advertisement
  • Click Here
  • Click Here
advertisement